| |
| SITE MAP |
Having trouble finding something? Use our site map. |
|
|
|
|
Latest Updates
May 2008 Marketed Drug Updates and Additions
Brand Name
|
Generic Name
|
Other Designation
|
| Leukine (USA), Interberin, Prokine |
Sargramostim |
|
| Zevalin |
Ibritumomab tiuxetan |
IDEC-Y2B8 |
| Sprycel |
Dasatinib |
BMS-354825 |
| TheraCIM HR3, TheraCIM h-R3, TheraCIM hR3 (USA), Theraloc (Europe), CIMAher (Latin America) |
Nimotuzumab |
YM-1001, OSAG101, h-R3, DE 766 |
| Zofran, Zofran ODT, Zofran Zydis |
Ondansetron |
|
| Erbitux |
Cetuximab |
IMC-C225 |
| Tasigna |
Nilotinib |
AMN107, AMN-107 |
| Navelbine |
Vinorelbine tartrate |
KW-2307 (Japan) |
| Zadaxin |
Thymalfasin |
|
| DepoCyt (USA), DepoCyte (formerly Savedar; Europe); formerly Depo/Ara C |
Cytarabine (ara-C), cytosine arabinoside |
DTC-101, NSC 63878 |
| Totect (USA), Savene (Europe) |
Dexrazoxane |
|
| Abelcet |
Amphotericin B lipid complex |
|
|